Form D · Investing
INVESTBIO VENTURES - AMPLIMED IV, L.P.
New York, NY · CIK 0001456303
Offering snapshot reported Sep 29, 2009 · SEC filing
- Reported sold
- $600K Offering amount: $2M
- Investors reported
- 22 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Aug 13, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 29, 2009 | Initial | $599,569 | No comparison | 22 | SEC filing |
| Jun 16, 2009 | Amendment | $1,068,032 | No comparison | 24 | SEC filing |
| Feb 10, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $60K
- Finders' fees
- $0
- Form D file number
- 021-126978
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| DPEC Capital, Inc. | 103737 | DPEC Capital, Inc. · CRD 103737 |
Source: Form D, filed Sep 29, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Scott L Mathis | Executive |
| Ronald S Robbins | Executive |
Issuer details
Industry: Investing (See others in industry)
Address:
135 Fifth Avenue 10 Th Floor
New York, NY, 10010
New York, NY, 10010